Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

This publication has 31 references indexed in Scilit:

• Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
  British Journal of Cancer, 2001
• Natural History of Neuroendocrine Enteropancreatic Tumors
  Digestion, 2000
• Internalization of radiolabelled [DTPA0]octreotide and [DOTA0, Tyr3]octreotide
  Nuclear Medicine Communications, 1998
• Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐d‐Phe¹]‐Octreotide
  Annals of the New York Academy of Sciences, 1994
• Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments
  Journal of Endocrinology, 1993
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Tolerance of normal tissue to therapeutic irradiation
  Published by Elsevier ,1991
• The radiation dose to cells in vitro from intracellular indium-111
  Biochemistry and Cell Biology, 1989
• Reporting results of cancer treatment
  Cancer, 1981